Cyclosporine-induced lipid peroxidation and propionyl carnitine protective effect

International Journal of Tissue Reactions

Volumn 21, Issue 1, 1999, Pages 7-11

  Longoni, B ^a   Giovannini, L ^b   Migliori, M ^b   Bertelli, A A E ^b   Bertelli, A ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE DERIVATIVE; CYCLOSPORIN; PROPIONYLCARNITINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; KIDNEY; LIPID ANALYSIS; LIPID PEROXIDATION; NONHUMAN; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARNITINE; CYCLOSPORINE; DRUG INTERACTIONS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY CORTEX; LIPID PEROXIDATION; RATS;

ANIMALIA;

EID: 0032868849     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kahan B. D. Cyclosporine. N. Engl. J. Med., 312, 1725, 1989.
2. Borel J.F., Feurer C., Stahelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology, 32, 1017, 1977.
3. Ryffel B. Pharmacology of cyclosporine. Pharmacolo. Rev., 41, 407, 1983.
4. Myers B.D. The long-term course of cyclosporine associated chronic nephropathy. Kidney Int., 33, 590, 1998.
5. McNally P.G. Feemally J. Pathophysiology of cyclosporin A nephrotoxicity. Experimental and clinical observation. Nephrol. Dial. Transplant., 7, 791, 1992.
6. Creagh T., Langan D., Dolan J., Terney W., Hayes D. Virol., 149, 915, 1993.
7. Remuzzi G., Bertani T. Renal vascular and thrombotic effects of cyclosporine. Am. J. Kidney Dis., 13, 241, 1989.
8. Bunchman T.E., Brookshire C.A. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. Clin. Invest., 88, 310, 1991.
9. Pestana M., Viera-Coelho M.A. et al. Assessment of renal dopaminergic system activity during cyclosporin A administration in the rat. Br. J. Pharmacol., 115, 1349, 1995.
10. Gardner M.P., Houghton D.C., Bennet W.M. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation, 61, 1506, 1996.
11. Giovannini L., Palla R., Bertelli A.A.E., et al. Cyclosporine nephrotoxicity evaluated by tissue calcium deposition is prevented by L-propionyl carnitine in isolated perfused rat kidney. Transplant. Proc., 28, 3122, 1996.
12. Giovannini L., Bertelli A. L-propionyl carnitine administration reduces toxicity related to ATP intracellular modification induced by cyclosporine. Drugs Exptl. Clin. Res. (in press).
13. Zidek W., Neumann K.H. Ca++ release in permeabilized human neutrophils induced by cyclosporine. Nephron., 56, 30, 1990.
14. Ruggementi P., Perico N., Mosconi L., Gaspari B., Begnigno A. Renal hypoperfusion calcium channel blockers protect transplant patients from cyclosporine induced. Kidney Int., 43, 706, 1993.
15. Wang C., Solahudeen A.K. Lipoperoxidation accompanies cyclosporine nephrotoxicity effects of vitamin E. Kidney Int., 47, 927, 1995.
16. Knight J.A., Cheung A.K., Servilla K. Increased urinary excretion of lipoperoxide levels in renal transplant patients. Ann. Clin. Lab. Sci., 19, 238, 1989.
17. Inselmann G., Hanneyman J., Bolmann K. Cyclosporin A induced lipid peroxidation and influence on glucose-6-phosphonase in rat hepatic and renal microsomes. Res. Com. Chem. Pathol. Pharmacol., 68, 189, 1990.
18. Ahmed S.S., Strobel H.W., Napoli K.L., Grevel J. Adenochrome reaction implicates oxygen radicals in metabolism of cyclosporin A and FK-506 in rat and human liver microsomes. J. Pharm. Expl. Ther., 263, 1047, 1993.
19. Mayers C.E., McGuire W.P., Liss R.H., Young R.C. Adriamycin: The role of lipoperoxidation in cardiac toxicity and tumor response. Science, 197, 165, 1977.
20. Bus J.S., Gibson Y.E. Paraquat: model for oxidant initiated toxicity. Environ. Health Perspect., 55, 37, 1984.
21. Freedman B.A., Grapo J.D. Biology of diseases, free radicals and tissue injury. Lab. Invest., 37, 412, 1982.
22. Lorgeril M., Boissonat F., Renaud S. The beneficial effect of dietary oxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients. Transplantation, 58, 193, 1994.
23. Bertelli A., Giovannini L., Palla R., Migliori M., Panichi V., Andreini B. Protective effect of L-propionyl carnitine on cyclosporine induced nephrotoxicity. Drugs. Exptl. Clin. Res., 21 (6), 221, 1995.
24. Lowry O.H., Rosenbrough N.Y., Farr A.L., Randall R.J. Protein measurement with the foliphenol folin reagent. J. Biol. Biol., 193, 265, 1951.
25. Weihel E.R. Point counting methods. In: Weihel E.R. (Ed.). "Sterological methods," Vol. 1. London Academic Press, London, 1979, pp 101.
26. Bertelli A., Conte A., Ronca G. L-propionyl carnitine protects erythrocytes and low density lipoproteiris against percxidation. Drugs Exptl. Clin. Res., 20 (5), 191, 1994.
27. Ronca F., Palmieri L., Malengo S., Bertelli A. Effect of L-propionyl carnitine on in-vitro membrane alteration of sickle-cell anemia erythrocytes. Int. J. Tiss. React., 16 (4), 187, 1994.
28. Conte A., Blanchi I, Guazzelli M., Taponeco G., Bertelli A, Ronca G. Effect of L-propionyl carnitine on some properties of erythrocytes and leukocytes of alcohol abusers. Int. J. Tiss. React., 17 (1), 21, 1995.
29. Bertelli A., Conte A., Ronca G., Segnini D., Yu G. Protective effect of L-propionyl carnitine against peroxidative damage to arterial endothelium membranes. Int. J. Tiss. React., 13 (1), 41, 1991.
30. Bertelli A., Ronca F., Segnini D., Yu G., Zucchi R. Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionyl carnitine. Drugs Exptl. Clin. Res., 18(11/12), 475, 1992.
31. Brooks D.P., Contino L.C. Prevention of cyclosporin A induced renal vasoconstriction by the endothelin receptor antagonist. Eur. J. Pharmacol., 294, 571, 1995.
32. Coffman T.M, Smith S.R., Klotman P.E. The thromboxane synthetase inhibitor CTG1308 improves renal allograft function in patients taking cyclosporin A. Kidney Int., 37, 604A, 1994.
33. Bobadilla N.A. Tapia E., Franco M., Herrera-A-Costa Y. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporine nephrotoxicity. Kidney Int., 37, 604A, 1994.
34. 2. Pediatric Res., 14, 625, 1986.